NCT05863481

Brief Summary

Preterm birth is a leading cause of neonatal mortality and morbidity. Cervical insufficiency is one factor implicated in the complex mechanisms involved in spontaneous preterm birth. Trans-abdominal insertion of a cervical cerclage suture can be used to treat cervical insufficiency. Growing evidence support that laparoscopic cerclage procedures are safe and effective. Still, many aspects of the laparoscopic cerclage remains uncertain. Therefore, the investigators plan to study the obstetric outcome from the first and subsequent pregnancies after laparoscopic cerclage in a Danish cohort from Aarhus University Hospital in a 10 years' period.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
10.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

August 3, 2023

Status Verified

May 1, 2023

Enrollment Period

10.1 years

First QC Date

May 4, 2023

Last Update Submit

August 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Neonatal survival (defined as survival at time of discharge from hospital)

    no. (reported for first, and consecutive deliveries)

    From birth until discharge, an average of 8 weeks

Secondary Outcomes (6)

  • Number of neonates surviving with major neonatal morbidity

    From birth until discharge, an average of 8 weeks

  • Number of pregnancies

    From the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)

  • Number of miscarriages

    From the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)

  • Deliveries

    From birth until discharge, an average of 8 weeks

  • Number of uterine ruptures

    From the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)

  • +1 more secondary outcomes

Other Outcomes (3)

  • Neonatal characteristics

    At delivery

  • Number of early complications from the laparoscopic cerclage procedure

    30 days from the procedure

  • Number of late complications from the laparoscopic cerclage procedure

    From the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)

Study Arms (1)

Laparoscopic cerclage

Patients who underwent laparoscopic cerclage at Aarhus University Hospital, Denmark in the study period

Procedure: Laparoscopic cerclage placement

Interventions

The surgical method of the laparoscopic cerclage procedure at Aarhus University Hospital previous described in a paper by Riiskjaer et al (DOI: 10.1111/aogs.12001)

Laparoscopic cerclage

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Persons at risk of preterm birth who were offered and underwent laparoscopic cerclage surgery at Aarhus University Hospital, Denmark in the period from May 2011 till May 2021.

You may qualify if:

  • Persons who underwent laparoscopic cerclage at Aarhus University Hospital, Denmark between May 2011 and May 2021

You may not qualify if:

  • Persons who had their laparoscopic cerclage performed subsequently to a trachelectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature BirthUterine Cervical Incompetence

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesAbortion, HabitualAbortion, SpontaneousGenital Diseases

Study Officials

  • Lise Q Krogh, MD

    Aarhus University Hospital/Aarhus University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 18, 2023

Study Start

May 1, 2011

Primary Completion

May 31, 2021

Study Completion

May 31, 2023

Last Updated

August 3, 2023

Record last verified: 2023-05